Skip to Main Content

Author Details

Daniel Delitto
Stanford University School of Medicine
2014
40
22
PMIDPaper TitleJournal TitlePublished Year
36270275Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin.Cancer Cell2022
35574257Surgical solution for a paraneoplastic neurodegenerative disorder.Trauma Surg Acute Care Open2022
35861852Postoperative Chemotherapy is Associated with Improved Survival in Patients with Node-Positive Pancreatic Ductal Adenocarcinoma After Neoadjuvant Therapy.World J Surg2022
35903565First Recurrence of Synovial Sarcoma Presenting With Solitary Pancreatic Mass.Cureus2022
33338577Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.J Am Coll Surg2021
34603324Machine Learning Applications in Solid Organ Transplantation and Related Complications.Front Immunol2021
34777919Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection.Oncoimmunology2021
32829009E-cigarette promotes breast carcinoma progression and lung metastasis: Macrophage-tumor cells crosstalk and the role of CCL5 and VCAM-1.Cancer Lett2020
31672677Protein Signatures and Tissue Diagnosis of Pancreatic Cancer.J Am Coll Surg2020
31929540The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC.PLoS One2020
32024069Nicotine Induces IL-8 Secretion from Pancreatic Cancer Stroma and Worsens Cancer-Induced Cachexia.Cancers (Basel)2020
32039571Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle.J Cachexia Sarcopenia Muscle2020
33117989Mysteries, Epistemological Modesty, and Artificial Intelligence in Surgery.Front Artif Intell2020
31384389Age-dependent response to multimodal therapy for stage II-III rectal cancer.Oncotarget2019
31769424IL-8 Released from Human Pancreatic Cancer and Tumor-Associated Stromal Cells Signals through a CXCR2-ERK1/2 Axis to Induce Muscle Atrophy.Cancers (Basel)2019
29165692Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.J Natl Cancer Inst2018
29984547Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease.Cancer2018
30464801Pathologic stage dictates survival after neoadjuvant radiation for rectal cancer.Oncotarget2018
30514931GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors.Nat Commun2018
30513792Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.Int J Mol Sci2018
30637373Skeletal Muscle Fibrosis in Pancreatic Cancer Patients with Respect to Survival.JNCI Cancer Spectr2018
29768025The Postinjury Inflammatory State and the Bone Marrow Response to Anemia.Am J Respir Crit Care Med2018
29191507Viscoelastic properties of human pancreatic tumors and in vitro constructs to mimic mechanical properties.Acta Biomater2018
27864347Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment.Cancer Res2017
28567575Analysis of the Cost Effectiveness of Laparoscopic Pancreatoduodenectomy.J Gastrointest Surg2017
28609371Orthotopic Patient-Derived Pancreatic Cancer Xenografts Engraft Into the Pancreatic Parenchyma, Metastasize, and Induce Muscle Wasting to Recapitulate the Human Disease.Pancreas2017
27932030A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer.Surgery2017
27901481Human pancreatic cancer xenografts recapitulate key aspects of cancer cachexia.Oncotarget2017
27102771Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture.Am J Pathol2016
28903323The pancreatic tumor microenvironment drives changes in miRNA expression that promote cytokine production and inhibit migration by the tumor associated stroma.Oncotarget2016
26667487Nicotine Reduces Survival via Augmentation of Paracrine HGF-MET Signaling in the Pancreatic Cancer Microenvironment.Clin Cancer Res2016
27260793Standardization of surgical care in a high-volume center improves survival in resected pancreatic head cancer.Am J Surg2016
27142633Oncologic and Perioperative Outcomes Following Selective Application of Laparoscopic Pancreaticoduodenectomy for Periampullary Malignancies.J Gastrointest Surg2016
27343757Targeting tumor tolerance: A new hope for pancreatic cancer therapy?Pharmacol Ther2016
25770474Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements.Am J Pathol2015
26384016Improved Breast Cancer Care Quality Metrics After Implementation of a Standardized Tumor Board Documentation Template.J Oncol Pract2015
26322418Primary outgrowth cultures are a reliable source of human pancreatic stellate cells.Lab Invest2015
26423423Downstream mediators of the intratumoral interferon response suppress antitumor immunity, induce gemcitabine resistance and associate with poor survival in human pancreatic cancer.Cancer Immunol Immunother2015
26498838The inflammatory milieu within the pancreatic cancer microenvironment correlates with clinicopathologic parameters, chemoresistance and survival.BMC Cancer2015
25024602c-Met signaling in the development of tumorigenesis and chemoresistance: potential applications in pancreatic cancer.World J Gastroenterol2014
  • 1 - 40 of 40

Recommended Authors

Sidney Kimmel Cancer Center at Thomas Jefferson University
Career Start Year 2017
Number of shared co-authors 0
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 0
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2015
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 2015
Number of shared co-authors 1
University of Colorado
Career Start Year 2014
Number of shared co-authors 0
Houston Methodist Hospital
Career Start Year 2012
Number of shared co-authors 0
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 0
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Career Start Year 2009
Number of shared co-authors 0
Universityhospital Frankfurt
Career Start Year 2007
Number of shared co-authors 0
University of Texas Southwestern Medical Center
Career Start Year 2006
Number of shared co-authors 1
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 1
Tisch Cancer Institute, Mount Sinai Hospital
Career Start Year 2005
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
University of Colorado
Career Start Year 2001
Number of shared co-authors 0
University of California san francisco
Career Start Year 1999
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
University of Cincinnati College of Medicine
Career Start Year 1996
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1993
Number of shared co-authors 1
National Defense Medical College
Career Start Year 1993
Number of shared co-authors 9
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 1
Dartmouth-Hitchcock Medical Center
Career Start Year 1991
Number of shared co-authors 0
Dartmouth-Hitchcock Medical Center
Career Start Year 1990
Number of shared co-authors 0
University of Pittsburgh
Career Start Year 1989
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1989
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1986
Number of shared co-authors 0
University of California San Diego
Career Start Year 1985
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1983
Number of shared co-authors 1

Collaborators

University of Florida Central Florida USA.
Co-authored papers 15
UF Health Cancer Center
Co-authored papers 13
University of Florida Health
Co-authored papers 7
Yale School of Public Health
Co-authored papers 6
University of Florida Health
Co-authored papers 6
University of Florida College of Medicine.
Co-authored papers 4
College of Medicine, University of Florida
Co-authored papers 3
University of Florida, Univerzitet u Sarajevu Medicinski Fakultet
Co-authored papers 2
University of Florida Health
Co-authored papers 2
University of Florida
Co-authored papers 2
University of Florida Health
Co-authored papers 1
University of Florida
Co-authored papers 1
University of Florida
Co-authored papers 1
University of Florida.
Co-authored papers 1
Harborview Medical Center, The University of Washington
Co-authored papers 1
University of Florida Health
Co-authored papers 1
Center for Personal Dynamic Regulomes, Stanford University
Co-authored papers 1
University of Florida College of Medicine
Co-authored papers 1
Moffitt Cancer Center
Co-authored papers 1
College of Medicine, University of Florida
Co-authored papers 1
College of Medicine, Diabetes Institute, University of Florida
Co-authored papers 1
University of Florida College of Medicine
Co-authored papers 1
Convergence Institute, Johns Hopkins University
Co-authored papers 1
University of Florida
Co-authored papers 1
Forensic and Scientific Services
Co-authored papers 1
Sepsis and Critical Illness Research Center, University of Florida
Co-authored papers 1
University of Florida
Co-authored papers 1
University of Florida Health
Co-authored papers 1